SW

Stacie Weninger

Executive Director at F-Prime Biomedical Research Initiative

Waban, Massachusetts

Investor
VC

Invests in

Stages:

Series A

Locations:

Massachusetts

  • Min Investment:

    $100,000.00

  • Max Investment:

    $10,000,000.00

  • Target Investment:

    $5,000,000.00

Education

Investments

Engrail Therapeutics

Series B

Total Funding: $220M

Neumora Therapeutics

Series A

Total Funding: $510M

Atalanta Therapeutics

Series A

Total Funding: $110M

Denali Therapeutics

Series A

Total Funding: $350M

Work Experience

F-Prime Biomedical Research Initiative

2009

  • Executive Director

    2009

    President, Alzforum

Fidelity

2005 - 2009

  • Science Program Director

    2005 - 2009

Harvard University

2005 - 2005

  • Senior Analyst and Project Manager, Task Force on Women in Science

    2005 - 2005

Cell Press

2001 - 2005

  • Senior Scientist, Neuron

    2001 - 2005